Cite
F-18 Fluorodeoxyglucose PET/CT as a Diagnostic Tool in Orbital Inflammatory Disorders.
MLA
Elourimi, Ghassan, et al. “F-18 Fluorodeoxyglucose PET/CT as a Diagnostic Tool in Orbital Inflammatory Disorders.” Ocular Immunology & Inflammation, vol. 30, no. 7/8, Oct. 2022, pp. 1803–09. EBSCOhost, https://doi.org/10.1080/09273948.2021.1957943.
APA
Elourimi, G., Soussan, M., Groh, M., Martin, A., Héran, F., Galatoire, O., Dhote, R., Vicaut, E., & Abad, S. (2022). F-18 Fluorodeoxyglucose PET/CT as a Diagnostic Tool in Orbital Inflammatory Disorders. Ocular Immunology & Inflammation, 30(7/8), 1803–1809. https://doi.org/10.1080/09273948.2021.1957943
Chicago
Elourimi, Ghassan, Michael Soussan, Matthieu Groh, Antoine Martin, Francoise Héran, Olivier Galatoire, Robin Dhote, Eric Vicaut, and Sébastien Abad. 2022. “F-18 Fluorodeoxyglucose PET/CT as a Diagnostic Tool in Orbital Inflammatory Disorders.” Ocular Immunology & Inflammation 30 (7/8): 1803–9. doi:10.1080/09273948.2021.1957943.